GE HealthCare Technologies Inc.
GEHC Healthcare Medical Devices
GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024.
- Revenue
- +7.19%
- EPS
- +40.6%
- Free cash flow
- +64.2%
- Total debt
- −1.90%
Quarter to September 2026, against a year earlier
Follow GEHC
Alert me
GE HealthCare Technologies Inc. (GEHC) EV/Sales
As of 5 November 2026, GE HealthCare Technologies Inc. (GEHC) trades at a EV/Sales of 2.1×. Over the past ten years it has ranged from 0.0× (December 2022) to 2.6× (March 2024); the current reading is higher than 49% of that period. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.2× | (1.70%) |
| FY2024 | 2.2× | (0.54%) |
| FY2023 | 2.2× | 25.75% |
| FY2022 | 1.8× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 1.8× | (2.04%) |
| Jun 2026 | 1.8× | (9.16%) |
| Mar 2026 | 2.0× | (7.94%) |
| Dec 2025 | 2.2× | 4.04% |
| 15 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | 1.6× |
| PHG Koninklijke Philips N.V. compare | 1.7× |
| GEHC GE HealthCare Technologies Inc. | 2.1× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 3.2× |
| BSX Boston Scientific Corporation compare | 3.6× |
| STE STERIS plc compare | 4.2× |
| DXCM DexCom, Inc. compare | 6.2× |
| EW Edwards Lifesciences Corporation compare | 8.2× |
| GKOS Glaukos Corporation compare | 18.8× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on GEHC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement